Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies

Clin Chem. 2004 Nov;50(11):2201-4. doi: 10.1373/clinchem.2004.038331.

Authors

María Collado¹, Olfert Landt, Eva Barragán, Ulrich Lass, José Cervera, Miguel A Sanz, Pascual Bolufer

Affiliation

¹ Laboratory of Molecular Biology, Department of Medical Biopathology, Clinical Hematology, Service of Hematology, Hospital Universitario La Fe, Valencia, Spain.

PMID: 15502100
DOI: 10.1373/clinchem.2004.038331

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Checkpoint Kinase 2
Child
Child, Preschool
Female
Germ-Line Mutation
Humans
Infant
Leukemia / genetics*
Male
Middle Aged
Myelodysplastic Syndromes / genetics*
Protein Serine-Threonine Kinases / genetics*
Spain

Substances

Checkpoint Kinase 2
CHEK2 protein, human
Protein Serine-Threonine Kinases